NO142381C - PROCEDURE FOR MANUFACTURING THE ANTIHEMOFILE FACTOR - Google Patents

PROCEDURE FOR MANUFACTURING THE ANTIHEMOFILE FACTOR

Info

Publication number
NO142381C
NO142381C NO2027/73A NO202773A NO142381C NO 142381 C NO142381 C NO 142381C NO 2027/73 A NO2027/73 A NO 2027/73A NO 202773 A NO202773 A NO 202773A NO 142381 C NO142381 C NO 142381C
Authority
NO
Norway
Prior art keywords
antihemofile
factor
procedure
manufacturing
antihemofile factor
Prior art date
Application number
NO2027/73A
Other languages
Norwegian (no)
Other versions
NO142381B (en
Inventor
Lajos F Fekete
Stephen L Holst
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of NO142381B publication Critical patent/NO142381B/en
Publication of NO142381C publication Critical patent/NO142381C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Medicinal Preparation (AREA)
NO2027/73A 1972-05-17 1973-05-16 PROCEDURE FOR MANUFACTURING THE ANTIHEMOFILE FACTOR NO142381C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (2)

Publication Number Publication Date
NO142381B NO142381B (en) 1980-05-05
NO142381C true NO142381C (en) 1980-08-13

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2027/73A NO142381C (en) 1972-05-17 1973-05-16 PROCEDURE FOR MANUFACTURING THE ANTIHEMOFILE FACTOR

Country Status (18)

Country Link
US (2) US3803115A (en)
JP (1) JPS596845B2 (en)
AT (1) AT344881B (en)
AU (1) AU465351B2 (en)
BE (1) BE799525A (en)
CA (1) CA1007986A (en)
CH (1) CH630804A5 (en)
DE (1) DE2324717C3 (en)
DK (1) DK136016B (en)
ES (1) ES414823A1 (en)
FR (1) FR2184898B1 (en)
GB (1) GB1372515A (en)
IL (1) IL42221A (en)
IT (1) IT1061433B (en)
NL (1) NL7306806A (en)
NO (1) NO142381C (en)
SE (1) SE430020B (en)
ZA (1) ZA733138B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (en) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Process for the production of sterile filtered cryoprecipitate with an enrichment of factor VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
AT359646B (en) * 1979-04-19 1980-11-25 Immuno Ag METHOD FOR PRODUCING SIDE-EFFECTIVE PLASMA FACTIONS
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
EP0033582B1 (en) * 1980-01-18 1984-04-11 The Canadian Red Cross Society Method of obtaining factor viii
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
ATE73820T1 (en) * 1986-03-27 1992-04-15 Octapharma Ag PROCESS FOR THE PRODUCTION OF A HIGHLY PURIFIED ANTIHAEMOPHILIA FACTOR.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (en) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine PROCESS FOR PREPARING A CONCENTRATE OF THE VON WILLEBRAND FACTOR VIII-FACTOR COMPLEX OF BLOOD COAGULATION FROM TOTAL PLASMA.
FR2657884B1 (en) * 1990-02-05 1994-09-02 Tm Innovation PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS.
IT1248723B (en) * 1990-06-12 1995-01-26 Scalvo S P A PROCESS FOR THE PURIFICATION OF FACTOR VIII AND FACTOR VIII OBTAINED WITH SUCH PROCESS
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
MXPA03007069A (en) * 2001-02-07 2004-10-15 Shanbrom Tech Llc Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (en) 1966-05-07 1966-11-10 Braun Fa B DRILLING WIRE STANDBY BOX.
BE713764A (en) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
GB1372515A (en) 1974-10-30
AT344881B (en) 1978-08-10
ATA433573A (en) 1975-04-15
US3803115A (en) 1974-04-09
AU5584973A (en) 1974-11-21
CA1007986A (en) 1977-04-05
NL7306806A (en) 1973-11-20
DK136016C (en) 1978-01-02
ZA733138B (en) 1974-03-27
FR2184898B1 (en) 1976-11-05
DE2324717B2 (en) 1980-01-03
DE2324717C3 (en) 1983-12-01
BE799525A (en) 1973-08-31
FR2184898A1 (en) 1973-12-28
JPS596845B2 (en) 1984-02-15
IL42221A0 (en) 1973-07-30
IT1061433B (en) 1983-02-28
SE430020B (en) 1983-10-17
NO142381B (en) 1980-05-05
USRE29698E (en) 1978-07-11
DK136016B (en) 1977-08-01
AU465351B2 (en) 1975-09-25
JPS4956695A (en) 1974-06-01
IL42221A (en) 1977-04-29
ES414823A1 (en) 1976-02-01
CH630804A5 (en) 1982-07-15
DE2324717A1 (en) 1973-12-13

Similar Documents

Publication Publication Date Title
NO142381C (en) PROCEDURE FOR MANUFACTURING THE ANTIHEMOFILE FACTOR
SE404019B (en) PROCEDURE FOR MAKING N-PHOSPHONOMETHYLGLYCIN
SE400771B (en) PROCEDURE FOR PREPARING 3ALFA-HYDROXI- AND 3ALFA-HYDROXI-19-NORPREGNANER
SE413246B (en) PROCEDURE FOR PREPARING CHOLESTEROLOXIDAS
FI53844B (en) FOERFARANDE FOER TILLVERKNING AV EN NAOLAD AENDLOES MASKINFILT
FI55326C (en) FOERFARANDE FOER FRAMSTAELLNING AV SKUMKERAMIK
SE419339B (en) PROCEDURE FOR PREPARING SUBSTITUTED SULPHONYLACETAMIDOCEPHALOSPORINES
NO139124C (en) PROCEDURE FOR PREPARING ESTERES
FI53620C (en) BRAENNUGN SPECIELLT FOER BRAENNING AV AVFALL
FI54072B (en) CENTRIFUGHJUL FOER CENTRIFUGERING AV SLAMNINGAR
FI54469B (en) FOERFARANDE FOER KOMPOSTERING AV AVLOPPSSLAM
SE392609B (en) PROCEDURE FOR THE PRODUCTION OF METHANE - GASES
NO149734C (en) PROCEDURE FOR MANUFACTURING UREA
FI55626C (en) PROCEDURE FOR FRAMSTAELLNING AV EN BEHAOLLARE
SE423540B (en) PROCEDURE FOR PREPARING CERTAIN 13-TIAPROSTAGLANDINES
FI54332B (en) FLUFALDIG ELEKTROLYSCELL FOER FRAMSTAELLNING AV ALKALIHYDROXIDER
FI53997B (en) ANORDNING FOER BEHANDLING AV FIBERHALTIGA SUSPENSIONER
FI54118B (en) FOERFARANDE FOER FRAMSTAELLNING AV LYSERGINSYRAAMIDER
SE402454B (en) PROCEDURE FOR PREPARING 2-ALCOXY-5-ALKYL SULPHONYL-TOLUENE
FI53935C (en) FOER FRAMSTAELLNING AV EN FOERPACKNING AV EXPANDERRAT PLASTMATERIAL
FI53773B (en) FOERFARANDE FOER FOERLAENGNING AV FAERSKFOERVARINGSTIDEN FOER FAERSKT KOETT
FI53471C (en) FOERFARANDE FOER BEHANDLING AV AVFALLSPAPPER
FI55289C (en) FOERFARANDE FOER FRAMSTAELLNING AV AETBAR BLANDNING I FORM AV KULOR
TR17286A (en) PROCEDURE FOR THE MANUFACTURING OF UERETHANES
FI55642B (en) FORM FOER FRAMSTAELLNING AV GLASPRODUKTER